Célia RABHI,our PhD student participated to the 7th ALS and Motor Neuron Disease Research Days which was be held in virtual format on October 12-13, 2021. She presented our work on the project 4P019. The title of her presentation is “HIGH CONTENT SCREEN OF SMALL MOLECULES INTERFERING WITH CYTOPLASMIC SELF-ASSEMBLIES OF TDP-43.”
For the second consecutive year, the Région Île-de-France launches “Paroles de chercheuses et chercheurs” operation. Through this program, thousands of high school students have the opportunity to meet researchers to discuss about their scientific professions and careers. 4P-Pharma is happy to participate to the second edition this year. For more information, click here!
Revital Rattenbach est l’invitée de Vincent Touraine dans Focus PME, une émission de BFM Business, qui sera diffusée le samedi 8 janvier 2022 à 15H25 et le dimanche 9 janvier 2022 à 16h55 Elle parlera d’innovation et des avancées de 4P-Pharma et de ses filiales, notamment 4Moving Biotech et 4Living Biotech. Pour plus d’information concernant la diffusion de l’émission: https://bfmbusiness.bfmtv.com/info/frequence/
Revital Rattenbach, chairwoman of 4P-Pharma, will attend the J.P. Morgan Week 2022 in San Francisco, January 10th-12th, 2022. Contact us via the partnering platform or by e-mail to schedule a meeting and discuss collaboration opportunities. For more information : https://events-export.businessfrance.fr/french-delegation-jp-morgan/
4Living Biotech and Sanofi signed a clinical collaboration agreement. The two companies will join their expertise to demonstrate the potential efficacy of Mozobil® as a treatment for acute and chronic complications of COVID-19. Pascal Rigaudy, Global Head, Transplant Brands at Sanofi, mentioned that “Through its collaboration with 4P-Pharma, Sanofi is delighted to continue to advance&hellip